稳定性同位素示踪技术研究进展及其在糖脂代谢研究中的应用( 三 )

[3] Wolfe RR. Stable isotope tracers applied to measuring rates of protein synthesis and breakdown in muscle: principles and applications. J Biomol Tech. 2011, 22 (Supplement): S12–S13.
[4] Fan TWM, Yuan P, Lane AN. Stable isotope-resolved metabolomic analysis of lithium effects on glial-neuronal metabolism and interactions. Metabolomics, 2010, 6:165-179.
[5] De Graaf AA, Maathuis A, De Waard P, et al. Profiling human gut bacterial metabolism and its kinetics using [U‐13C] glucose and NMR. NMR in Biomedicine, 2010, 23: 2-12.
[6] Harber MP, Dickinson JM, Crane JD, et al. Influence of tracer selection on protein synthesis rates at rest and postexercise in multiple human muscles. Metabolism, 2011, 60: 689-697.
[7] Kamphorst JJ, Fan J, Lu W, et al. Liquid chromatography–high resolution mass spectrometry analysis of fatty acid metabolism. Anal Chem, 2011, 83: 9114-9122.
[8] Hiller K, Metallo C, Stephanopoulos G. Elucidation of cellular metabolism via metabolomics and stable-isotope assisted metabolomics. Curr Pharm Biotechnol, 2011, 12:1075-86.
Elucidation of cellular metabolism via metabolomics and stable-isotope assisted metabolomics.
[9] Bier DM, Arnold KJ, Sherman WR, et al. In-vivo measurement of glucose and alanine metabolism with stable isotopic tracers. Diabetes,1977, 26:1005-1015.
[10] Basu R, Schwenk WF, Rizza RA. Both fasting glucose production and disappearance are abnormal in people with" mild" and" severe" type 2 diabetes.Am J Physiol Endocrinol Metab, 2004, 287: E55-E62.
[11] Basu R, Di Camillo B, Toffolo G. Use of a novel triple-tracer approach to assess postprandial glucose metabolism. AJP -Endo, 2003, 284:E55-E69.
[12] Kacerovsky M, Jones J, Schmid AI, et al.Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes. Diabetes, 2011,60:1752-1758.
[13] Basu R, Singh RJ, Basu A, et al. Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans. JCEM, 2005, 90:3919-3926.
[14] McQuaid SE, Hodson L, Neville MJ, et al. Downregulation of adipose tissue fatty acid trafficking in obesity. Diabetes, 2011, 60:47-55.
[15] Basu A, Basu R, Shah P, et al. Systemic and regional free fatty acid metabolism in type 2 diabetes.AJP - Endo, 2001, 280: E1000-E1006.
[16] Basu R, Singh RJ, Basu A, et al. Splanchnic Cortisol production occurs in humans evidence for conversion of cortisone to cortisol via the 11-β hydroxysteroid dehydrogenase (11β-hsd) type 1 pathway. Diabetes, 2004, 53 :2051-2059.
[17] Kahn SE, Zinman B, Lachin JM, et al. Rosiglitazone-associated fractures in type 2 diabotes: an analysis from a diabetes outcome progression trial(ADOPT). Diabetes Care, 2008, 31: 845-851.
[18] Basu R, Man CD, Campioni M, et al. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women. Diabetes, 2007, 56:3753-3766.
[19] Zhai HL, Wu H, Xu H, et al. Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats. Reprod Biol Endocrin, 2012, 10:5.